Ligand validation:4WO1

OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate

OLC is a Ligand Of Interest in 4WO1 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4WO1_OLC_B_101	20%	60%	0.185	0.787	0.64	0.88	-	1	1	0	100%	1
4WO1_OLC_B_102	18%	59%	0.201	0.789	0.65	0.88	-	-	3	0	100%	1
4WO1_OLC_D_101	17%	70%	0.161	0.839	0.31	0.82	-	-	0	0	44%	0.44
4WO1_OLC_A_102	12%	67%	0.187	0.826	0.44	0.8	-	-	1	0	40%	0.4
4WO1_OLC_D_102	10%	60%	0.212	0.712	0.69	0.83	-	-	2	0	100%	1
4WO1_OLC_C_101	4%	57%	0.236	0.608	0.59	1.03	-	2	2	0	100%	0.9016
4WOL_OLC_B_101	17%	60%	0.212	0.791	0.58	0.93	-	1	0	0	100%	1
7Z0C_OLC_A_803	63%	52%	0.097	0.892	0.82	1.04	1	2	2	0	100%	1
4N6H_OLC_A_1222	62%	56%	0.117	0.932	0.81	0.87	1	1	0	0	88%	0.88
5IU4_OLC_A_2429	61%	58%	0.136	0.926	0.8	0.78	2	1	1	0	100%	1
6G7H_OLC_A_310	61%	92%	0.117	0.905	0.26	0.26	-	-	0	0	100%	1
7B0O_OLC_A_302	59%	55%	0.146	0.929	0.68	1.06	1	1	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.